BioStem Technologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2017
Period Ending	Feb '26 Feb 13, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '17 Dec 31, 2017
Market Capitalization	93	230	95	36	10	86
Market Cap Growth	-62.75%	142.79%	161.02%	267.00%	-88.46%	124.88%
Enterprise Value	69	220	101	40	11	87
Last Close Price	5.52	13.84	5.86	2.99	1.04	12.00
PE Ratio	6.47	7.23	-	-	-	-
PS Ratio	0.32	0.76	5.69	5.29	2.28	273.98
PB Ratio	1.85	5.64	-70.60	-9.21	-1.71	108.42
P/TBV Ratio	1.87	5.70	-	-	-	246.78
P/FCF Ratio	-	-	-	606.05	-	-
P/OCF Ratio	-	-	-	119.78	-	-
EV/Sales Ratio	0.24	0.73	6.04	5.87	2.53	276.69
EV/EBITDA Ratio	4.44	7.01	-	-	-	-
EV/EBIT Ratio	4.51	7.06	-	-	-	-
EV/FCF Ratio	-	-	-	672.38	-	-
Debt / Equity Ratio	0.07	0.11	-3.55	-1.32	-0.84	1.26
Debt / EBITDA Ratio	0.22	0.14	-	-	-	-
Debt / FCF Ratio	-	-	-	86.82	-	-
Asset Turnover	3.51	3.90	1.85	2.24	-	0.12
Inventory Turnover	2.62	11.07	2.39	2.69	-	1.25
Quick Ratio	3.87	1.29	0.74	0.13	0.10	0.06
Current Ratio	4.31	1.35	0.81	0.24	0.14	0.21
Return on Equity (ROE)	55.46%	161.31%	-	-	-	-756.22%
Return on Assets (ROA)	11.47%	25.17%	-48.94%	-95.34%	-	-112.20%
Return on Capital Employed (ROCE)	30.50%	75.70%	665.50%	163.60%	41.50%	-356.20%
Earnings Yield	21.78%	13.84%	-8.94%	-19.78%	-14.59%	-5.58%
FCF Yield	-	-	-3.80%	0.17%	-1.54%	-2.09%
Buyback Yield / Dilution	-21.37%	-58.30%	-20.18%	2.40%	-130.37%	-43.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.